Guideline development for the management of gout: role of combination therapy with a focus on lesinurad
Graeme Jones,1 Elena Panova,1 Richard Day2 1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; 2University of New South Wales, Medicine, St Vincent’s Hospital, Sydney, NSW, Australia Abstract: The aim of this review was to summarize the evidence for com...
Saved in:
Main Authors: | Jones G (Author), Panova E (Author), Day R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]
by: Jones G, et al.
Published: (2017) -
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019) -
Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
by: Gillen M, et al.
Published: (2016) -
The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout
by: N. Ughi, et al.
Published: (2019) -
Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study
by: Youssef Saeed Alghamdi, et al.
Published: (2020)